Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow Cytometry Core at CIMA LAB Diagnostics, on X adding:

“Excellent work in Blood Cancer Journal by Martín-Sánchez, Bruno Paiva, et al.

You’ve seen their work on flow cytometry predicting MGUS-like vs not.

But now, flow cytometry to predict when to offer boosters to patients with multiple myeloma.”

Quoting Bruno Paiva’s post:

“New paper alert in Blood Cancer Journal.

Interest in immune response to infection and vaccines started during COVID19 and pivoted to a new research line in our lab!

Thanks L. Esteban Tamariz-Amador, Camila Guerrero, Paula Rodriguez-Otero, University of Navarra Clinic, Cima University of Navarra.”

Source: Rahul Banerjee/X and Bruno Paiva/X

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.

Authors: Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Bruno Paiva and The Basque-Navarra Association of Hematology and Hemotherapy (ASOVASNA) cooperative group.

Flow cytometry to predict when to offer boosters to patients with multiple myeloma